High frequency of mitochondrial complex I mutations in Parkinson's disease and aging

Neurobiology of Aging

Volumn 25, Issue 10, 2004, Pages 1273-1281

  Smigrodzki, Rafal ^a   Parks, Janice ^a   Parker, W Davis ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Complex I deficiency; Mitochondrial DNA mutations; Parkinson's disease

Indexed keywords

MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

AGED; AGING; AMINO ACID SEQUENCE; ARTICLE; COMPLEX I DEFICIENCY; CONTROLLED STUDY; FRONTAL CORTEX; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ALGORITHM; GENETIC CODE; GENETIC VARIABILITY; HETEROPLASMY; HUMAN; HUMAN TISSUE; MITOCHONDRIAL GENETICS; MOLECULAR CLONING; PARKINSON DISEASE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AGED; AGED, 80 AND OVER; AGING; COMORBIDITY; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MITOCHONDRIAL DISEASES; PARKINSON DISEASE; PREVALENCE; UNITED STATES;

EID: 4644351698     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.02.020     Document Type: Article

References (87)

1. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 90(17):1993;7915-7922
2. Anderson J.J., Bravi D., Ferrari R., Davis T.L., Baronti F., Chase T.N., et al. No evidence for altered muscle mitochondrial function in Parkinson's disease. J. Neurol. Neurosurg. Psych. 56(5):1993;477-480
3. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M., Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 23(2):1999;147
4. Benecke R., Strumper P., Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain. 116(Part 6):1993;1451-1463
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3(12):2000;1301-1306
6. Bhagwat A.S., Lieb M. Cooperation and competition in mismatch repair: very short-patch repair and methyl-directed mismatch repair in Escherichia coli. Mol. Microbiol. 44(6):2002;1421-1428
7. Bindoff L.A., Birch-Machin M.A., Cartlidge N.E., Parker W.D.J., Turnbull D.M. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 104(2):1991;203-208
8. Blin O., Desnuelle C., Rascol O., Borg M., Peyro S., Azulay J.P., et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J. Neurol. Sci. 125(1):1994;95-101
9. Brierley E.J., Johnson M.A., Lightowlers R.N., James O.F., Turnbull D.M. Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann. Neurol. 43(2):1998;217-223
10. Brown M.D., Shoffner J.M., Kim Y.L., Jun A.S., Graham B.H., Cabell M.F., et al. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. Am. J. Med. Genet. 61(3):1996;283-289
11. Cardellach F., Marti M.J., Fernandez-Sola J., Marin C., Hoek J.B., Tolosa E., et al. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology. 43(11):1993;2258-2262
12. Cassarino D.S., Fall C.P., Swerdlow R.H., Smith T.S., Halvorsen E.M., Miller S.W., et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta. 1362(1):1997;77-86
13. Chinnery P.F., Samuels D.C., Elson J., Turnbull D.M. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? Lancet. 360(9342):2002;1323-1325
14. Cline J., Braman J.C., Hogrefe H.H. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucl. Acids Res. 24(18):1996;3546-3551
15. Corral-Debrinski M., Horton T., Lott M.T., Shoffner J.M., McKee A.C., Beal M.F., et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics. 23(2):1994;471-476
16. Corral-Debrinski M., Shoffner J.M., Lott M.T., Wallace D.C. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat. Res. 275(3-6):1992;169-180
17. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94(9):1997;4526-4531
18. De Coo I.F., Renier W.O., Ruitenbeek W., Ter Laak H.J., Bakker M., Schagger H., et al. A 4-base pair deletion in the mitochondrial cytochrome b gene associated with Parkinsonism/MELAS overlap syndrome. Ann. Neurol. 45(1):1999;130-133
19. Dohet C., Wagner R., Radman M. Methyl-directed repair of frameshift mutations in heteroduplex DNA. Proc. Natl. Acad. Sci. U.S.A. 83(10):1986;3395-3397
20. Fang W., Wu J.Y., Su M.J. Methyl-directed repair of mismatched small heterologous sequences in cell extracts from Escherichia coli. J. Biol. Chem. 272(36):1997;22714-22720
21. Gahan M.E., Miller F., Lewin S.R., Cherry C.L., Hoy J.F., Mijch A., et al. Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction. J. Clin. Virol. 22(3):2001;241-247
22. Garcia-Lozano J.R., Mir P., Alberca R., Aguilera I., Gil N., Fernandez-Lopez O., et al. Mitochondrial DNA A4336G mutation in Alzheimer's and Parkinson's diseases. Eur. Neurol. 48(1):2002;34-36
23. Grasbon-Frodl E.M., Kosel S., Sprinzl M., von Eitzen U., Mehraein P., Graeber M.B. Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease. Neurogenetics. 2(2):1999;121-127
24. Gu G., Reyes P.E., Golden G.T., Woltjer R.L., Hulette C., Montine T.J., et al. Mitochondrial DNA deletions/rearrangements in Parkinson disease and related neurodegenerative disorders. J. Neuropathol. Exp. Neurol. 61(7):2002;634-639
25. Gu M., Cooper J.M., Taanman J.W., Schapira A.H. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann. Neurol. 44(2):1998;177-186
26. Haas R.H., Nasirian F., Nakano K., Ward D., Pay M., Hill R., et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann. Neurol. 37(6):1995;714-722
27. Hattori N., Yoshino H., Tanaka M., Suzuki H., Mizuno Y. Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. Genomics. 49(1):1998;52-58
28. Hirano M., Shtilbans A., Mayeux R., Davidson M.M., DiMauro S., Knowles J.A., et al. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc. Natl. Acad. Sci. U.S.A. 94(26):1997;14894-14899
29. Ikebe S., Tanaka M., Ohno K., Sato W., Hattori K., Kondo T., et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem. Biophys. Res. Commun. 170(3):1990;1044-1048
30. Ikebe S., Tanaka M., Ozawa T. Point mutations of mitochondrial genome in Parkinson's disease. Brain Res. Mol. Brain Res. 28(2):1995;281-295
31. Jellinger K.A. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol. Chem. Neuropathol. 14(3):1991;153-197
32. Jensen M.A., Straus N. Effect of PCR conditions on the formation of heteroduplex and single-stranded DNA products in the amplification of bacterial ribosomal DNA spacer regions. PCR Meth. Appl. 3(3):1993;186-194
33. Kirby D.M., Boneh A., Chow C.W., Ohtake A., Ryan M.T., Thyagarajan D., et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease. Ann. Neurol. 54:2003;473-478
34. Kirchner S.C., Hallagan S.E., Farin F.M., Dilley J., Costa-Mallen P., Smith-Weller T., et al. Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson's disease. Neurotoxicology. 21(4):2000;441-445
35. Kosel S., Grasbon-Frodl E.M., Hagenah J.M., Graeber M.B., Vieregge P. Parkinson disease: analysis of mitochondrial DNA in monozygotic twins. Neurogenetics. 2(4):2000;227-230
36. Kosel S., Grasbon-Frodl E.M., Mautsch U., Egensperger R., von E., Frishman D., et al. Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics. 1(3):1998;197-204
37. Krige D., Carroll M.T., Cooper J.M., Marsden C.D., Schapira A.H. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann. Neurol. 32(6):1992;782-788
38. Lahue R.S., Au K.G., Modrich P. DNA mismatch correction in a defined system. Science. 245(4914):1989;160-164
39. Lin M.T., Simon D.K., Ahn C.H., Kim L.M., Beal M.F. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11(2):2002;133-145
40. Liolitsa D., Rahman S., Benton S., Carr L.J., Hanna M.G. Is the mitochondrial complex I ND5 gene hot-spot for MELAS causing mutations? Ann. Neurol. 53:2003;128-132
41. Mann V.M., Cooper J.M., Krige D., Daniel S.E., Schapira A.H., Marsden C.D. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinsons's disease. Brain. 115(Part 2):1992;333-342
42. Miller F.J., Rosenfeldt F.L., Zhang C., Linnane A.W., Nagley P. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. Nucl. Acids Res. 31(11):2003;e61
43. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163(3):1989;1450-1455
44. Modrich P. DNA mismatch correction. Annu. Rev. Biochem. 56:1987;435-466
45. Modrich P. Methyl-directed DNA mismatch correction. J. Biol. Chem. 264(12):1989;6597-6600
46. Ng P.C., Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucl. Acids Res. 31(13):2003;3812-3814
47. Nicklas W.J., Vyas I., Heikkila R.E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36(26):1985;2503-2508
48. Ozawa T., Tanaka M., Ikebe S., Ohno K., Kondo T., Mizuno Y. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in Parkinsonian striatum by a kinetic PCR analysis. Biochem. Biophys. Res. Commun. 172(2):1990;483-489
49. Ozawa T., Tanaka M., Ino H., Ohno K., Sano T., Wada Y., et al. Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem. Biophys. Res. Commun. 176(2):1991;938-946
50. Parker W.D. Jr., Filley C.M., Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology. 40(8):1990;1302-1303
51. Parker W.D. Jr., Mahr N.J., Filley C.M., Parks J.K., Hughes D., Young D.A., et al. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology. 44(6):1994;1086-1090
52. Parker W.D.J., Boyson S.J., Parks J.K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26(6):1989;719-723
53. Parks J.K., Swerdlow R.H., Parker W.D. Decreased NADH ubiquinone oxidoreductase in frontal cortex in Parkinson's disease. Soc. Neurosci. Abstr. 25:1999;1337
54. Pulkes T., Eunson L., Patterson V., Siddiqui A., Wood N.W., Nelson I.P., et al. The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS. Ann. Neurol. 46(6):1999;916-919. (erratum appears in Ann. Neurol. 2000;47(6):841)
55. Reichmann H., Janetzky B., Bischof F., Seibel P., Schols L., Kuhn W., et al. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. Eur. Neurol. 34(5):1994;263-267
56. Richter G., Sonnenschein A., Grunewald T., Reichmann H., Janetzky B. Novel mitochondrial DNA mutations in Parkinson's disease. J. Neural Transm. 109(5-6):2002;721-729
57. Ross OA, McCormack R, Maxwell LD, Duguid RA, Quinn DJ, Barnett YA, et al. mt4216C Variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish. Exp Gerontol, in press.
58. Rossignol R., Faustin B., Rocher C., Malgat M., Mazat J.P., Letellier T. Mitochondrial threshold effects. Biochem. J. 370:2003;751-762
59. Ruano G., Kidd K.K. Modeling of heteroduplex formation during PCR from mixtures of DNA templates. PCR Meth. Appl. 2(2):1992;112-116
60. Santorelli F.M., Tanji K., Kulikova R., Shanske S., Vilarinho L., Hays A.P., et al. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem. Biophys. Res. Commun. 238(2):1997;326-328
61. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54(3):1990;823-827
62. Sheehan J.P., Swerdlow R.H., Parker W.D., Miller S.W., Davis R.E., Tuttle J.B. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J. Neurochem. 68(3):1997;1221-1233
63. Shoffner J.M., Brown M.D., Torroni A., Lott M.T., Cabell M.F., Mirra S.S., et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics. 17(1):1993;171-184
64. Shoffner J.M., Watts R.L., Juncos J.L., Torroni A., Wallace D.C. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol. 30(3):1991;332-339
65. Shults C.W., Miller S.W. Reduced complex I activity in Parkinsonian cybrids. Movement Disord. 13(2):1998;217
66. Simon D, Standaert DG, Johns DR, Flint Beal M, Cantuti-Castelvetri I, Zheng K, et al. Accumulation of somatic mitochondrial DNA mutations in single neurons from the human brain. Neurology 2003 (supplement AAN meeting).
67. Simon D.K., Lin M.T., Ahn C.H., Liu G.J., Gibson G.E., Beal M.F., et al. Low mutational burden of individual acquired mitochondrial DNA mutations in brain. Genomics. 73(1):2001;113-116
68. Simon D.K., Mayeux R., Marder K., Kowall N.W., Beal M.F., Johns D.R. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease. Neurology. 54(3):2000;703-709
69. Smith M.A., Sayre L.M., Anderson V.E., Harris P.L., Beal M.F., Kowall N., et al. Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4- dinitrophenylhydrazine. J. Histochem. Cytochem. 46(6):1998;731-735
70. Suter M., Richter C. Fragmented mitochondrial DNA is the predominant carrier of oxidized DNA bases. Biochemistry. 38(1):1999;459-464
71. Swerdlow R.H., Parks J.K., Davis J.N., Cassarino D.S., Trimmer P.A., Currie L.J., et al. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann. Neurol. 44(6):1998;873-881
72. Swerdlow R.H., Parks J.K., Miller S.W., Tuttle J.B., Trimmer P.A., Sheehan J.P., et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40(4):1996;663-671
73. Tanaka M. Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease. J. Neurol. 249(Suppl. 2):2002;II11-II18
74. Tanaka M., Fuku N., Takeyasu T., Guo L.J., Hirose R., Kurata M., et al. Golden mean to longevity: rareness of mitochondrial cytochrome b variants in centenarians but not in patients with Parkinson's disease. J. Neurosci. Res. 70(3):2001;347-355
75. Thompson J.R., Marcelino L.A., Polz M.F. Heteroduplexes in mixed-template amplifications: formation, consequence by 'reconditioning PCR'. Nucl. Acids Res. 30(9):2002;2083-2088
76. Thyagarajan D., Bressman S., Bruno C., Przedborski S., Shanske S., Lynch T., et al. A novel mitochondrial 12S rRNA point mutation in Parkinsonism, deafness, and neuropathy. Ann. Neurol. 48(5):2000;730-736
77. Triepels R.H., Van D., Trijbels J.M., Smeitink J.A. Respiratory chain complex I deficiency. Am. J. Med. Genet. 106(1):2001;37-45
78. Trimmer P.A. PD cybrids contain inclusion bodies that share antigenic determinants with Lewy bodies. Soc. Neurosci. Abstr. 25(2):1999;1336
79. Trimmer PA, Borland MK, Bennett JP, Keeney PM, Parker WD. Transgenic mitochondrial cybrids generate Lewy inclusion bodies. J Neurochem, in press.
80. Trimmer P.A., Swerdlow R.H., Parks J.K., Keeney P., Bennett J.P.J., Miller S.W., et al. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp. Neurol. 162(1):2000;37-50
81. Vives-Bauza C., Andreu A.L., Manfredi G., Beal M.F., Janetzky B., Gruenewald T.H., et al. Sequence analysis of the entire mitochondrial genome in Parkinson's disease. Biochem. Biophys. Res. Commun. 290(5):1908;1593-1601
82. Wallace DC. In: Rosenberg RN, Barchi RL, DiMauro S, Prusiner SB, editors. The molecular and genetic basis of neurological disease. Boston: Butterworths/Heinemann, 1997. p. 237-69.
83. Wallace D.C., Stugard C., Murdock D., Schurr T., Brown M.D. Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc. Natl. Acad. Sci. U.S.A. 94(26):1997;14900-14905
84. Wooten G.F., Currie L.J., Bennett J.P., Harrison M.B., Trugman J.M., Parker W.D. Jr. Maternal inheritance in Parkinson's disease. Ann. Neurol. 41(2):1997;265-268
85. Xia X., Xie Z. Protein structure, neighbor effect, and a new index of amino acid dissimilarities. Mol. Biol. Evol. 19(1):2002;58-67
86. Yoshino H., Nakagawa-Hattori Y., Kondo T., Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J. Neural Transm. - Parkinsons Dis. Dementia Section. 4(1):1992;27-34
87. Zhang J., Montine T.J., Smith M.A., Siedlak S.L., Gu G., Robertson D., et al. The mitochondrial common deletion in Parkinson's disease and related movement disorders. Parkinsonism Relat. Disord. 8(3):2002;165-170